IL6 and colitis: Deletion of 5-HT2B from the mouse model of chemically induced colitis leads to an increased level of IL-6 and an accompanying upregulation of STAT3 activation, which boosts the survival and proliferation of intestinal epithelial cells during inflammation, leading to cancer initiation.